9-Benzyl-11-iodo-1,4-dioxa-9-azadispiro[4.2.4.2]tetradecane

Catalog No. :
ACMYZC691
CAS No. :
635728-14-2
Molecular Formula :
C18H24INO2
Molecular Weight :
413.30

IUPAC Name:9-benzyl-11-iodo-1,4-dioxa-9-azadispiro[4.2.48.25]tetradecane

9-Benzyl-11-iodo-1,4-dioxa-9-azadispiro[4.2.4.2]tetradecane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$140.00Login to see priceInquiryInquiry
250mg95%$302.00Login to see priceInquiryInquiry
1g95%$754.00Login to see priceInquiryInquiry
5g95%$2263.00Login to see priceInquiryInquiry
10g95%$2738.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name9-Benzyl-11-iodo-1,4-dioxa-9-azadispiro[4.2.4.2]tetradecane
IUPAC Name9-benzyl-11-iodo-1,4-dioxa-9-azadispiro[4.2.48.25]tetradecane
MDL No.MFCD28166312
Molecular FormulaC18H24INO2
Molecular Weight413.30
SMILESIC(C1)CN(CC2=CC=CC=C2)C1(CC3)CCC43OCCO4
InChI KeyOQRFPUIWLRKDBA-UHFFFAOYSA-N
Synonym1,4-Dioxa-9-azadispiro[4.2.4.2]tetradecane, 11-iodo-9-(phenylmethyl)-;9-benzyl-11-iodo-1,4-dioxa-9-azadispiro[4.2.48.25]tetradecane;9-Benzyl-11-iodo-1,4-dioxa-9-azadispiro[4.2.4.2]tetradecane
CAS No.635728-14-2
PubChem CID67075634

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACMYZC691 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMYZC691 route product structure diagram
    ACMYZC691635728-14-2
Inquiry

2. ACMYZC691 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMYZC691 route product structure diagram
    ACMYZC691635728-14-2
Inquiry

Comments (0)